Mantle Biotech
Cambridge · Founded 2019
About Mantle Biotech
Mantle Biotech engineers binding proteins that can accurately identify disease biomarkers in patient samples, using directed evolution to modify heat-stable proteins produced by microbes. It allows the company to develop new diagnostic capabilities, producing high-quality binding proteins that are more stable and affordable than traditional reagents. This reagents can be adapted to a range of diseases and test formats, allowing the team to identify pain points throughout the broader diagnostic industry. Mantle Biotech was founded on 2019 and is headquartered in Cambridge, Massachusetts.
Company Facts
- Founded: 2019
- Legal name: MANTLE BIOTECHNOLOGIES, INC.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Non-Equity Assistance (Oct 2020)
- Website: mantlebiotech.com
Social Profiles
Canonical: https://fsome.com/organization/mantle-biotech-8432235 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.